Harrow Emerging As Dominant Operator In U.S. Ophthalmic Market

The best opportunity is when the other folks are panicking, but you keep your head. And that time is right. Now.Thanks for reading my research. If you want to learn even more about my research process and what stocks I like, check out my subscription marketplace service Concentrated Value with MVI . You'll get:Harrow, Inc. ( HROW ), is emerging as a dominant player in the US ophthalmic pharmaceuticals space. The company has grown revenue almost 30-fold since it began operations in 2015, led by its ambitious ...